| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.13e-04 | 20 | 16 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.27e-04 | 749 | 16 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 4.38e-04 | 39 | 16 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.49e-03 | 72 | 16 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.01e-03 | 323 | 16 | 3 | GO:1901681 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.13e-05 | 412 | 16 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.48e-05 | 1186 | 16 | 7 | GO:0007167 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.58e-05 | 8 | 16 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.64e-05 | 445 | 16 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.00e-05 | 218 | 16 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.41e-05 | 482 | 16 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 2.70e-05 | 850 | 16 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 3.03e-05 | 80 | 16 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | response to growth factor | 3.35e-05 | 883 | 16 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.22e-04 | 347 | 16 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.32e-04 | 131 | 16 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 1.97e-04 | 150 | 16 | 3 | GO:0090288 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.80e-04 | 169 | 16 | 3 | GO:0010977 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 3.50e-04 | 36 | 16 | 2 | GO:1904754 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.65e-04 | 185 | 16 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.65e-04 | 185 | 16 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | negative regulation of SMAD protein signal transduction | 4.11e-04 | 39 | 16 | 2 | GO:0060392 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 4.26e-04 | 195 | 16 | 3 | GO:0030178 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 4.33e-04 | 40 | 16 | 2 | GO:0097242 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 4.38e-04 | 197 | 16 | 3 | GO:0030509 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 4.55e-04 | 41 | 16 | 2 | GO:1901889 | |
| GeneOntologyBiologicalProcess | circulatory system development | 5.02e-04 | 1442 | 16 | 6 | GO:0072359 | |
| GeneOntologyBiologicalProcess | response to BMP | 5.66e-04 | 215 | 16 | 3 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 5.66e-04 | 215 | 16 | 3 | GO:0071773 | |
| GeneOntologyBiologicalProcess | limb development | 6.38e-04 | 224 | 16 | 3 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 6.38e-04 | 224 | 16 | 3 | GO:0048736 | |
| GeneOntologyBiologicalProcess | negative regulation of ossification | 6.76e-04 | 50 | 16 | 2 | GO:0030279 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 7.15e-04 | 233 | 16 | 3 | GO:0031345 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 9.73e-04 | 60 | 16 | 2 | GO:0099054 | |
| GeneOntologyBiologicalProcess | regulation of vascular associated smooth muscle cell migration | 1.11e-03 | 64 | 16 | 2 | GO:1904752 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 1.13e-03 | 273 | 16 | 3 | GO:0030323 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.17e-03 | 276 | 16 | 3 | GO:0007179 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell migration | 1.32e-03 | 70 | 16 | 2 | GO:1904738 | |
| GeneOntologyBiologicalProcess | presynapse organization | 1.44e-03 | 73 | 16 | 2 | GO:0099172 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.61e-03 | 309 | 16 | 3 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 1.61e-03 | 1189 | 16 | 5 | GO:0044087 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.85e-03 | 83 | 16 | 2 | GO:0060976 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell migration | 1.85e-03 | 83 | 16 | 2 | GO:0014911 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 2.05e-03 | 336 | 16 | 3 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 2.17e-03 | 90 | 16 | 2 | GO:0060390 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.17e-03 | 343 | 16 | 3 | GO:0071559 | |
| GeneOntologyBiologicalProcess | heart development | 2.30e-03 | 757 | 16 | 4 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 2.40e-03 | 355 | 16 | 3 | GO:0043523 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 2.42e-03 | 95 | 16 | 2 | GO:0002090 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 2.65e-03 | 368 | 16 | 3 | GO:0030111 | |
| GeneOntologyBiologicalProcess | kidney development | 2.74e-03 | 372 | 16 | 3 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 3.04e-03 | 386 | 16 | 3 | GO:0072001 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 3.22e-03 | 110 | 16 | 2 | GO:0060395 | |
| GeneOntologyBiologicalProcess | tube development | 3.34e-03 | 1402 | 16 | 5 | GO:0035295 | |
| GeneOntologyBiologicalProcess | neuron apoptotic process | 3.68e-03 | 413 | 16 | 3 | GO:0051402 | |
| GeneOntologyBiologicalProcess | hair follicle development | 4.01e-03 | 123 | 16 | 2 | GO:0001942 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 4.01e-03 | 123 | 16 | 2 | GO:0045666 | |
| GeneOntologyBiologicalProcess | molting cycle process | 4.20e-03 | 126 | 16 | 2 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 4.20e-03 | 126 | 16 | 2 | GO:0022405 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 4.46e-03 | 130 | 16 | 2 | GO:1905477 | |
| HumanPheno | Microspherophakia | 9.70e-06 | 4 | 7 | 2 | HP:0030961 | |
| HumanPheno | Iridodonesis | 1.62e-05 | 5 | 7 | 2 | HP:0100693 | |
| HumanPheno | Spherophakia | 1.62e-05 | 5 | 7 | 2 | HP:0034375 | |
| HumanPheno | Aplasia/Hypoplasia of the lens | 1.69e-04 | 15 | 7 | 2 | HP:0008063 | |
| HumanPheno | Abnormality of lens shape | 2.45e-04 | 18 | 7 | 2 | HP:0011526 | |
| HumanPheno | Shallow anterior chamber | 2.45e-04 | 18 | 7 | 2 | HP:0000594 | |
| MousePheno | abnormal limb bud morphology | 1.60e-06 | 91 | 14 | 4 | MP:0005650 | |
| MousePheno | syndactyly | 1.75e-06 | 93 | 14 | 4 | MP:0000564 | |
| MousePheno | thick apical ectodermal ridge | 5.58e-06 | 4 | 14 | 2 | MP:0001678 | |
| MousePheno | abnormal limb development | 8.92e-06 | 140 | 14 | 4 | MP:0006279 | |
| MousePheno | abnormal digit morphology | 1.08e-05 | 323 | 14 | 5 | MP:0002110 | |
| MousePheno | ectopic digits | 1.39e-05 | 6 | 14 | 2 | MP:0000568 | |
| MousePheno | abnormal forelimb morphology | 2.51e-05 | 182 | 14 | 4 | MP:0000550 | |
| MousePheno | abnormal autopod morphology | 2.68e-05 | 390 | 14 | 5 | MP:0000572 | |
| MousePheno | abnormal heart ventricle morphology | 6.63e-05 | 793 | 14 | 6 | MP:0005294 | |
| MousePheno | craniofacial phenotype | 1.59e-04 | 1372 | 14 | 7 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.59e-04 | 1372 | 14 | 7 | MP:0000428 | |
| MousePheno | abnormal apical ectodermal ridge morphology | 2.13e-04 | 22 | 14 | 2 | MP:0001676 | |
| MousePheno | polydactyly | 2.59e-04 | 129 | 14 | 3 | MP:0000562 | |
| MousePheno | abnormal limb morphology | 2.80e-04 | 1028 | 14 | 6 | MP:0002109 | |
| MousePheno | microphthalmia | 3.60e-04 | 362 | 14 | 4 | MP:0001297 | |
| MousePheno | diaphragmatic hernia | 3.72e-04 | 29 | 14 | 2 | MP:0003924 | |
| MousePheno | abnormal eye size | 4.12e-04 | 375 | 14 | 4 | MP:0002697 | |
| MousePheno | abnormal body wall morphology | 4.12e-04 | 151 | 14 | 3 | MP:0003385 | |
| MousePheno | abnormal ectoderm morphology | 4.54e-04 | 32 | 14 | 2 | MP:0014139 | |
| MousePheno | abnormal metacarpal bone morphology | 6.08e-04 | 37 | 14 | 2 | MP:0003073 | |
| MousePheno | limbs/digits/tail phenotype | 8.36e-04 | 1258 | 14 | 6 | MP:0005371 | |
| MousePheno | omphalocele | 1.25e-03 | 53 | 14 | 2 | MP:0003052 | |
| MousePheno | absent kidney | 1.25e-03 | 53 | 14 | 2 | MP:0000520 | |
| MousePheno | abnormal jaw morphology | 1.51e-03 | 530 | 14 | 4 | MP:0000454 | |
| MousePheno | abnormal hindlimb morphology | 2.05e-03 | 576 | 14 | 4 | MP:0000556 | |
| MousePheno | abnormal viscerocranium morphology | 2.28e-03 | 593 | 14 | 4 | MP:0005274 | |
| MousePheno | abnormal phalanx morphology | 2.54e-03 | 76 | 14 | 2 | MP:0005306 | |
| MousePheno | abnormal diaphragm morphology | 2.68e-03 | 78 | 14 | 2 | MP:0002279 | |
| MousePheno | abnormal trachea morphology | 2.88e-03 | 81 | 14 | 2 | MP:0002282 | |
| MousePheno | abnormal abdominal wall morphology | 2.95e-03 | 82 | 14 | 2 | MP:0003257 | |
| MousePheno | atrioventricular septal defect | 3.10e-03 | 84 | 14 | 2 | MP:0010412 | |
| MousePheno | embryonic lethality between implantation and somite formation, complete penetrance | 3.31e-03 | 311 | 14 | 3 | MP:0011096 | |
| MousePheno | abnormal atrioventricular septum morphology | 3.32e-03 | 87 | 14 | 2 | MP:0010592 | |
| MousePheno | abnormal pelvic girdle bone morphology | 3.32e-03 | 87 | 14 | 2 | MP:0004509 | |
| MousePheno | hunched posture | 3.62e-03 | 91 | 14 | 2 | MP:0001505 | |
| MousePheno | embryonic lethality between implantation and somite formation | 4.25e-03 | 340 | 14 | 3 | MP:0006205 | |
| Domain | EGF_CA | 7.72e-09 | 86 | 16 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.42e-08 | 97 | 16 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.58e-08 | 99 | 16 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.66e-08 | 100 | 16 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.23e-08 | 106 | 16 | 5 | IPR000152 | |
| Domain | EGF | 2.68e-08 | 235 | 16 | 6 | SM00181 | |
| Domain | EGF-like_dom | 3.79e-08 | 249 | 16 | 6 | IPR000742 | |
| Domain | EGF_CA | 4.52e-08 | 122 | 16 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.90e-08 | 124 | 16 | 5 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 1.55e-07 | 156 | 16 | 5 | IPR009030 | |
| Domain | EGF_3 | 1.18e-06 | 235 | 16 | 5 | PS50026 | |
| Domain | cEGF | 1.33e-06 | 26 | 16 | 3 | PF12662 | |
| Domain | cEGF | 1.33e-06 | 26 | 16 | 3 | IPR026823 | |
| Domain | EGF_1 | 1.76e-06 | 255 | 16 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.98e-06 | 261 | 16 | 5 | IPR013032 | |
| Domain | EGF_2 | 2.13e-06 | 265 | 16 | 5 | PS01186 | |
| Domain | TB | 1.44e-05 | 7 | 16 | 2 | PF00683 | |
| Domain | - | 1.92e-05 | 8 | 16 | 2 | 3.90.290.10 | |
| Domain | TB_dom | 2.47e-05 | 9 | 16 | 2 | IPR017878 | |
| Domain | TB | 2.47e-05 | 9 | 16 | 2 | PS51364 | |
| Domain | Ldl_recept_b | 6.22e-05 | 14 | 16 | 2 | PF00058 | |
| Domain | LDLRB | 6.22e-05 | 14 | 16 | 2 | PS51120 | |
| Domain | LY | 7.18e-05 | 15 | 16 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.18e-05 | 15 | 16 | 2 | IPR000033 | |
| Domain | EGF | 1.57e-04 | 126 | 16 | 3 | PF00008 | |
| Domain | - | 5.01e-04 | 39 | 16 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 5.27e-04 | 40 | 16 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 6.67e-04 | 45 | 16 | 2 | PF00057 | |
| Domain | - | 6.97e-04 | 46 | 16 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.97e-04 | 46 | 16 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 7.58e-04 | 48 | 16 | 2 | PS01209 | |
| Domain | LDLa | 7.90e-04 | 49 | 16 | 2 | SM00192 | |
| Domain | LDLRA_2 | 7.90e-04 | 49 | 16 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.90e-04 | 49 | 16 | 2 | IPR002172 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.35e-04 | 25 | 10 | 2 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.22e-04 | 32 | 10 | 2 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.98e-04 | 37 | 10 | 2 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.14e-04 | 38 | 10 | 2 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.31e-04 | 39 | 10 | 2 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.22e-04 | 44 | 10 | 2 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.81e-04 | 47 | 10 | 2 | M646 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.02e-03 | 300 | 10 | 3 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.29e-03 | 77 | 10 | 2 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.91e-03 | 94 | 10 | 2 | M1041 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 2.61e-03 | 110 | 10 | 2 | MM15977 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.99e-03 | 118 | 10 | 2 | MM15588 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 1.98e-07 | 2 | 16 | 2 | 24484584 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 24867584 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 19936252 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 28513615 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 17293099 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 21700711 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 21540769 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 20301293 | ||
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 20383322 | ||
| Pubmed | Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. | 1.98e-06 | 5 | 16 | 2 | 16263759 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 19047013 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 19182256 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 10848613 | ||
| Pubmed | 7.13e-06 | 9 | 16 | 2 | 23986861 | ||
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 24639464 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.26e-05 | 100 | 16 | 3 | 25807483 | |
| Pubmed | Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. | 1.54e-05 | 13 | 16 | 2 | 16207730 | |
| Pubmed | 2.06e-05 | 118 | 16 | 3 | 21078624 | ||
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 20205790 | ||
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 21531785 | ||
| Pubmed | 4.15e-05 | 21 | 16 | 2 | 19806668 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 4.15e-05 | 21 | 16 | 2 | 21337463 | |
| Pubmed | Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. | 8.57e-05 | 30 | 16 | 2 | 21946350 | |
| Pubmed | 1.10e-04 | 34 | 16 | 2 | 26288816 | ||
| Pubmed | 1.10e-04 | 34 | 16 | 2 | 23293290 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.87e-04 | 248 | 16 | 3 | 24006456 | |
| Pubmed | 3.23e-04 | 58 | 16 | 2 | 23284291 | ||
| Interaction | ZFP41 interactions | 1.17e-05 | 57 | 16 | 3 | int:ZFP41 | |
| Interaction | LCE3D interactions | 2.47e-05 | 73 | 16 | 3 | int:LCE3D | |
| Interaction | ZNF778 interactions | 3.24e-05 | 11 | 16 | 2 | int:ZNF778 | |
| Interaction | C17orf50 interactions | 3.88e-05 | 12 | 16 | 2 | int:C17orf50 | |
| GeneFamily | Low density lipoprotein receptors | 1.71e-05 | 13 | 9 | 2 | 634 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 3.27e-05 | 104 | 16 | 3 | M45682 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 5.94e-05 | 19 | 16 | 2 | M12084 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 7.44e-05 | 137 | 16 | 3 | M40313 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 2.05e-04 | 35 | 16 | 2 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.05e-04 | 35 | 16 | 2 | M11788 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.08e-04 | 194 | 16 | 3 | M39122 | |
| Coexpression | LEF1_UP.V1_UP | 2.08e-04 | 194 | 16 | 3 | M2905 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.17e-04 | 36 | 16 | 2 | MM1212 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP | 2.21e-04 | 198 | 16 | 3 | M9929 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 2.28e-04 | 200 | 16 | 3 | M9922 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.28e-04 | 200 | 16 | 3 | M5930 | |
| Coexpression | NABA_MATRISOME | 2.55e-04 | 1008 | 16 | 5 | MM17056 | |
| Coexpression | NABA_MATRISOME | 2.77e-04 | 1026 | 16 | 5 | M5889 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 4.21e-04 | 50 | 16 | 2 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 4.55e-04 | 52 | 16 | 2 | MM1118 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_1 | 4.55e-04 | 52 | 16 | 2 | M2135 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.97e-04 | 261 | 16 | 3 | M1834 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 5.72e-04 | 274 | 16 | 3 | M289 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-09 | 197 | 16 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-09 | 197 | 16 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-09 | 197 | 16 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-09 | 197 | 16 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.76e-09 | 199 | 16 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.76e-09 | 199 | 16 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.93e-09 | 200 | 16 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.93e-09 | 200 | 16 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.93e-09 | 200 | 16 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.93e-09 | 200 | 16 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-07 | 168 | 16 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-07 | 171 | 16 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-07 | 175 | 16 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-07 | 179 | 16 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.44e-07 | 181 | 16 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-07 | 183 | 16 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.06e-07 | 187 | 16 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.50e-07 | 191 | 16 | 4 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.50e-07 | 191 | 16 | 4 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-07 | 192 | 16 | 4 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.62e-07 | 192 | 16 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.74e-07 | 193 | 16 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.86e-07 | 194 | 16 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-07 | 195 | 16 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-07 | 195 | 16 | 4 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.98e-07 | 195 | 16 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-07 | 195 | 16 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-07 | 195 | 16 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-07 | 196 | 16 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 197 | 16 | 4 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.35e-07 | 198 | 16 | 4 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.35e-07 | 198 | 16 | 4 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.35e-07 | 198 | 16 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.35e-07 | 198 | 16 | 4 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.35e-07 | 198 | 16 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 6.35e-07 | 198 | 16 | 4 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 199 | 16 | 4 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.48e-07 | 199 | 16 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.48e-07 | 199 | 16 | 4 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.48e-07 | 199 | 16 | 4 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.61e-07 | 200 | 16 | 4 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 2.22e-05 | 156 | 16 | 3 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 157 | 16 | 3 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-05 | 157 | 16 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 158 | 16 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 161 | 16 | 3 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 161 | 16 | 3 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 161 | 16 | 3 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.53e-05 | 163 | 16 | 3 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.57e-05 | 164 | 16 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-05 | 165 | 16 | 3 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-05 | 168 | 16 | 3 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-05 | 168 | 16 | 3 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.81e-05 | 169 | 16 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-05 | 169 | 16 | 3 | 0c341f91dc21aaf92bead18d59684d11510502ce | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 170 | 16 | 3 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 170 | 16 | 3 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.02e-05 | 173 | 16 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-05 | 175 | 16 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 176 | 16 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.17e-05 | 176 | 16 | 3 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 176 | 16 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 176 | 16 | 3 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.34e-05 | 179 | 16 | 3 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-05 | 179 | 16 | 3 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.34e-05 | 179 | 16 | 3 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.39e-05 | 180 | 16 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.45e-05 | 181 | 16 | 3 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 182 | 16 | 3 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-05 | 182 | 16 | 3 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 182 | 16 | 3 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.51e-05 | 182 | 16 | 3 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 183 | 16 | 3 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 184 | 16 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 185 | 16 | 3 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 185 | 16 | 3 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-05 | 185 | 16 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-05 | 185 | 16 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.68e-05 | 185 | 16 | 3 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-05 | 186 | 16 | 3 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-05 | 186 | 16 | 3 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-05 | 186 | 16 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.80e-05 | 187 | 16 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| Computational | Metal / Ca ion binding. | 2.09e-04 | 133 | 10 | 3 | MODULE_324 | |
| Computational | ECM and collagens. | 9.74e-04 | 225 | 10 | 3 | MODULE_47 | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A | 9.12e-06 | 197 | 16 | 4 | 435_DN | |
| Disease | Weill-Marchesani syndrome | 8.27e-07 | 3 | 16 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 8.27e-07 | 3 | 16 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 8.27e-07 | 3 | 16 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 1.65e-06 | 4 | 16 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.65e-06 | 4 | 16 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | intraocular pressure measurement | 5.59e-06 | 509 | 16 | 5 | EFO_0004695 | |
| Disease | aortic aneurysm | 1.24e-05 | 10 | 16 | 2 | EFO_0001666 | |
| Disease | Marfan Syndrome | 1.51e-05 | 11 | 16 | 2 | C0024796 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 5.21e-05 | 20 | 16 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | neuroticism measurement | 9.03e-05 | 909 | 16 | 5 | EFO_0007660 | |
| Disease | suicidal ideation | 1.11e-04 | 29 | 16 | 2 | EFO_0004320 | |
| Disease | spontaneous coronary artery dissection | 1.27e-04 | 31 | 16 | 2 | EFO_0010820 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 2.94e-04 | 47 | 16 | 2 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | FEV/FEC ratio | 3.68e-04 | 1228 | 16 | 5 | EFO_0004713 | |
| Disease | pulmonary function measurement, FEV/FEC ratio | 3.74e-04 | 53 | 16 | 2 | EFO_0003892, EFO_0004713 | |
| Disease | feeling "fed-up" measurement | 7.67e-04 | 76 | 16 | 2 | EFO_0009588 | |
| Disease | descending aortic diameter | 1.03e-03 | 88 | 16 | 2 | EFO_0021788 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEDVIYDDVPCESPD | 126 | Q9HCE6 | |
| EEDEEGYCPRCQELE | 316 | Q6ZU67 | |
| ECADEPCDAYEVEQT | 41 | Q8N9N2 | |
| EPKEECDERTCEPYQ | 3526 | Q07954 | |
| EVQDPDYEECVPCEE | 1026 | Q92824 | |
| DPPVVYQVEDVCEEE | 581 | Q8NDX5 | |
| CTDDSPDPCIEYELV | 151 | O75794 | |
| EECEECPMRNTPEYE | 991 | P35555 | |
| IPEDYDVCAEAPCEQ | 86 | Q6UXH8 | |
| ECVDIDECEDYGDPV | 1256 | Q14767 | |
| QPYPCAEDEECGTDE | 81 | O94907 | |
| EDDDEEDCPNPEEYN | 401 | P78362 | |
| EEPELEPLCCCEYID | 16 | Q8IYP9 | |
| CHEEEEEDNCYEVEP | 616 | Q8N895 | |
| DCAVPECVNPVYEPE | 151 | B2RUY7 | |
| DEQDCPPRECEEDEF | 101 | O75096 |